As Roche’s new spinal muscular atrophy (SMA) drug, Evresdi, gains steam, Novartis is hoping some new trial data can help its gene therapy Zolgensma stand out in the increasingly competitive field. In phase 3 data from the SPR1NT study presented at the European Academy for Neurology virtual congress, Zolgensma met its primary and secondary goals… Read More »
So you think you can dance—for Adakveo? Novartis’ latest campaign asks people to bust a move to raise awareness around sickle cell anemia and its branded treatment. Led by well-known hip-hop dancer Stephen “tWitch” Boss, who also appears on “The Ellen DeGeneres Show” as a DJ, the “Do U” campaign invites the public to create… Read More »
Pharma companies including Pfizer, Novartis and AbbVie have paused advertising on Facebook for July. Their brands join others in the Stop Hate for Profit campaign, meant to pressure Facebook into taking action against hate and disinformation spread on its platform. Pfizer is the largest of the pharma companies participating and one of three overall top 25… Read More »